- Report
- April 2025
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- October 2024
- 192 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- February 2025
- 240 Pages
Global
From €2448EUR$2,690USD£2,099GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- January 2025
- 135 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- May 2024
- 136 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 129 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 132 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 133 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- October 2024
- 210 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- August 2024
- 233 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Clinical Trials
- December 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2024
- 250 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Drug Pipelines
- August 2024
- 150 Pages
Global
From €2538EUR$2,789USD£2,176GBP
- Report
- February 2025
- 60 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- August 2022
- 117 Pages
Global
From €4095EUR$4,500USD£3,511GBP

Carbamazepine is a drug used to treat epilepsy and other neurological disorders. It is classified as an anticonvulsant and is used to treat seizures, trigeminal neuralgia, and bipolar disorder. It works by decreasing the activity of certain nerve cells in the brain, which helps to reduce the frequency and severity of seizures. It is also used to treat certain types of pain, such as trigeminal neuralgia. Carbamazepine is a member of the Central Nervous System (CNS) drug class, which includes drugs used to treat neurological disorders.
Carbamazepine is available in both generic and brand-name forms. It is available in tablet, capsule, and liquid forms, and is usually taken twice a day. The dosage and duration of treatment depend on the condition being treated. Common side effects of carbamazepine include dizziness, drowsiness, nausea, and vomiting.
Some companies in the Carbamazepine market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more